Antimicrobial nanocoatings — including peptides like melimine and Mel4 — can reduce bacteria on contact lenses by over 99.9% and have shown clinical benefits in reducing eye infections.
>99.9% bacterial reductionAntimicrobial nanocoatings on contact lenses achieved greater than 3-log10 (99.9%) reductions in bacteria, and clinical trials have shown these coatings reduce corneal infiltrative events — the early stages of lens-related eye infections.
What the researchers found
Antimicrobial nanocoatings for contact lenses — including antimicrobial peptides like melimine and Mel4, metallic nanoparticles, polymeric layers, and hybrid systems — can achieve greater than 3-log10 (99.9%) bacterial reductions and have reduced corneal infiltrative events in clinical trials. AMPs and peptidomimetics are among the most promising approaches, preventing microbial adhesion and biofilm formation while maintaining lens biocompatibility. The field is moving toward hybrid, stimuli-responsive coatings that activate only under infection-specific conditions.
Why it matters
Microbial keratitis from contact lens wear affects 2-24 per 10,000 wearers annually and can cause permanent vision loss. With increasing contact lens use — especially for myopia control in children — safer lens designs are urgently needed. Antimicrobial peptide coatings offer a particularly attractive solution because they fight infections through mechanisms that bacteria are unlikely to develop resistance against, unlike conventional antibiotics.
How the study worked
Systematic literature review analyzing publications from PubMed, Scopus, and Web of Science (2008-2025). The review covers metallic nanoparticle coatings (silver, zinc oxide, titanium dioxide), organo-selenium coatings, polymeric layers, antimicrobial peptides (melimine, Mel4), and peptidomimetics. Key topics include coating techniques (surface grafting, dip-coating, plasma treatment), antimicrobial mechanisms, and outcomes from both preclinical and clinical trials.
Who was studied
Review covering contact lens wearers at risk of microbial keratitis, with data from preclinical studies and clinical trials
What this study cannot tell us
Several challenges remain: nanoparticle toxicity at certain concentrations, peptide degradation over the lens wear period, regulatory hurdles for novel coated medical devices, and the need for long-term safety data. Most coatings have been tested primarily against Gram-positive and Gram-negative bacteria, with less evidence against fungal or Acanthamoeba keratitis. Manufacturing scalability and cost for peptide-coated lenses are not fully addressed.
How to read the evidence
This is a comprehensive literature review covering preclinical and clinical trial data from 2008-2025. The evidence base ranges from in vitro studies to clinical trials (particularly for the Mel4 peptide), representing a relatively mature translational pipeline for antimicrobial peptide applications in medical devices.
When this study was published
Published in 2026 with literature coverage through 2025, this is an extremely current review capturing the latest advances in antimicrobial contact lens coatings, including emerging stimuli-responsive and hybrid approaches.
The bigger picture
As antimicrobial resistance makes eye infections harder to treat with antibiotics, peptide-based coatings for medical devices like contact lenses represent a practical application of antimicrobial peptide research. The Mel4 peptide has already progressed through clinical trials on contact lenses — one of the most advanced real-world applications of antimicrobial peptides in any medical device. With contact lens use expanding globally, particularly for myopia control in children, these coatings could prevent millions of infections.
Questions still open
- Can antimicrobial peptide coatings maintain their activity throughout the full wear cycle of extended-wear contact lenses?
- Will stimuli-responsive 'smart' coatings that activate under infection conditions prove practical and safe for commercial lenses?
- How will regulatory agencies classify peptide-coated contact lenses, and what safety data will be required for approval?
Common questions
How do antimicrobial peptides on contact lenses prevent infections?
Are peptide-coated contact lenses available to buy now?
Read the original research
Antimicrobial nanocoatings and films for contact lenses: progress and promise.
Nanomedicine (London, England), 21(5), 683-690
Citation
Sara, Manjulatha; Attard, Samuel; Kumar, Naresh; Willcox, Mark. (2026). Antimicrobial nanocoatings and films for contact lenses: progress and promise.. Nanomedicine (London, England), 21(5), 683-690. https://doi.org/10.1080/17435889.2026.2623930